As healthcare converts to an entirely electronic health record (EHR)-based system, it opens up new opportunities to ...
With the world’s elderly population expected to double by 2050, understanding how aging affects the body is an important focus for researchers globally. Cardiovascular disease, the No. 1 cause of death worldwide, often is associated with aging arteries that restrict blood flow. Now, University of Missouri researchers have identified an age-related cause of arterial dysfunction, a finding that could lead to future treatments for some forms of vascular disease.
The U.S. Food and Drug Administration (FDA) will hold a pair of public workshops in November to explain ongoing efforts to develop regulations and standards for next-generation sequencing (NGS)-based clinical tests. The focus on NGS tests is part of President Obama’s Precision Medicine Initiative (PMI) to help customize healthcare for individuals based on genetic makeup.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
University of Texas Southwestern cardiologist Benjamin Levine, M.D., will use NASA-honed technology to monitor swimmer Ben Lecomte in his record-setting goal to become the first person to swim across the Pacific Ocean. Lecomte will plunge into the ocean off of a Tokyo beach this summer heading for San Francisco.
Zoll Medical Corp. announced that it has acquired Tel Aviv, Israel-based Kyma Medical Technologies Ltd., which develops technologies to measure early signs of congestive heart failure.
Cook Medical has received premarket approval from the U.S. Food and Drug Administration (FDA) for its lower-profile Zenith Alpha Thoracic endovascular graft.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
For the first time, European Society of Cardiology (ESC) guidelines give the highest degree of recommendation for the radial over the femoral approach for coronary angiography and percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS). The ACS without persistent ST-segment elevation (NSTE-ACS) guidelines, drafted by an international multidisciplinary task force, are published online in European Heart Journal and on the ESC website.
St. Jude Medical Inc. announced European CE Mark approval for the 27mm and 29mm Portico transcatheter aortic valve replacement (TAVR) system. The approval follows previous approvals of the 23mm and 25mm Portico valves, allowing St. Jude Medical to offer physicians an expanded range of fully repositionable, retrievable TAVR valve sizes. The Portico valve accommodates a patient’s native anatomy with diameters ranging from 19 to 27 mm.
SynCardia Systems initiated a Class I recall of the Freedom Driver Systems used with the company’s temporary Total Artificial Heart (TAH-t) on Aug. 6, 2015. The recall focused on a specific part of the Freedom Driver drive mechanism that the company said may fail and cause the device to stop pumping.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
MedLumics has announced the completion of a successful single-case pre-clinical feasibility study of its optical coherence tomography (OCT) technology in the catheter ablation treatment of atrial fibrillation (AF).
At the National Nuclear Security Administration’s (NNSA) 2015 Mo-99 Topical Meeting, Novation offered its support of efforts to encourage the adoption of processes to create a reliable domestic supply of non-highly enriched uranium (HEU) molybdenum-99 (Mo-99).
According to a new Centers for Disease Control (CDC) Vital Signs report, 3 out of 4 U.S. adults have a predicted heart age that is older than their actual age. This means they are at higher risk for heart attacks and stroke.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The Institute for Clinical and Economic Review (ICER) has released a new report offering a comprehensive review of currently available evidence on two new interventions as potential advances in the care of congestive heart failure (CHF) patients. The report is titled CardioMEMS HF System (St. Jude Medical) and Sacubitril/Valsartan (Entresto, Novartis) for Management of Congestive Heart Failure: Effectiveness, Value, and Value-Based Price Benchmarks.
Thoratec Corp. issued a voluntary Urgent Medical Device Correction Letter to all hospitals who have patients supported with the HeartMate II LVAS reminding them to monitor the expiration date of the backup battery contained within the HeartMate II "Pocket" System Controller, as specified in the product Instructions for Use. This backup battery has a 36-month expiration date. If allowed to expire, an advisory alarm, indicated by a yellow wrench symbol, is triggered. This alarm occurs at 12:00 a.m. on the first day of the month in which the backup battery expires.
September 16, 2015 — Initial results of a landmark clinical trial found patients randomized to a systolic blood pressure ...
September 22, 2015
